Cart
sales@molnova.com
Home - Products - Endocrinology/Hormones - Androgen Receptor (AR) - BMS-641988 B

BMS-641988 B

CAS No. 1093276-09-5

BMS-641988 B( —— )

Catalog No. M36006 CAS No. 1093276-09-5

BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 248 Get Quote
5MG 380 Get Quote
10MG 570 Get Quote
25MG 882 Get Quote
50MG 1178 Get Quote
100MG 1575 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    BMS-641988 B
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
  • Description
    BMS-641988 is a novel nonsteroidal androgen receptor antagonist for the treatment of prostate cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1093276-09-5
  • Formula Weight
    471.45
  • Molecular Formula
    C20H20F3N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@]12[C@@]3([C@]([C@@](C)(O1)[C@H](NS(CC)(=O)=O)C2)(C(=O)N(C3=O)C4=CC(C(F)(F)F)=C(C#N)C=C4)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • VPC-14228

    VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.

  • Mesterolone

    Mesterolone is an orally applicable androgen and dihydrotestosterone (DHT) derivative.

  • Dimethylcurcumin

    Dimethylcurcumin (ASC-J9) is an androgen receptor degradation enhancer. It effectively suppresses castration-resistant prostate cancer cell proliferation and invasion.Dimethylcurcumin is able to degrade fAR and AR3 in a dose-dependent manner in various human PCa cells. Dimethylcurcumin can also effectively suppress AR-targeted genes in CWR22Rv1-fARKD cells.

Sign In Join Free